系统性红斑狼疮患儿的严重血液系统受累及其临床关联
该研究回顾性分析了224例系统性红斑狼疮患儿的病历,其中102例(45.5%)出现严重血液系统指标(血红蛋白<8 g/dl的自身免疫性溶血性贫血、血小板<30 000/µL、中性粒细胞<500/µL)。严重指标多出现在初始受累时,未影响疾病活动度或损伤累积;但血液系统复发者的损伤率(51.1% vs 29.9%,P=0.002)和激素所致损伤率(28.9% vs 8.2%,P<0.001)更高。初始发作时使用利妥昔单抗(OR:4.5,P=0.006)和抗心磷脂抗体阳性(OR:2.3,P=0.014)显著增加血液系统复发的 odds。
要点
- 严重血液系统指标在起病时常见(45.5%),但未增加疾病活动度或损伤累积。
- 血液系统复发者损伤率(51.1% vs 29.9%,P=0.002)和激素所致损伤率(28.9% vs 8.2%,P<0.001)更高。
- 初始发作时利妥昔单抗治疗(OR:4.5,P=0.006)和抗心磷脂抗体阳性(OR:2.3,P=0.014)与血液系统复发风险升高相关。
核心结论
- 起病时的严重血液系统指标常见,但与疾病结局无关。
- 预防复发对改善结局重要,对常规免疫抑制剂难治的血液系统指标患儿及抗心磷脂抗体阳性者,更严格的维持策略可能获益最大。
研究设计与样本
- 回顾性病历审查,纳入224例系统性红斑狼疮患儿,其中观察到血液系统受累者纳入分析。
- 严重血液系统指标定义为:血红蛋白<8 g/dl的自身免疫性溶血性贫血、血小板计数<30 000/µL、中性粒细胞计数<500/µL。
主要发现
- 224例中102例(45.5%)出现严重指标,多数在初始受累时,最常见为严重贫血54例(24.1%)和严重血小板减少45例(20.1%)。
- 疾病活动度在有无严重疾病指标者之间无差异。
- 初始受累时存在严重指标不影响损伤累积。
- 血液系统复发者的损伤率(51.1% vs 29.9%,P=0.002)和激素所致损伤率(28.9% vs 8.2%,P<0.001)更高。
- 回归分析显示,初始发作时利妥昔单抗治疗(OR:4.5,P=0.006)和抗心磷脂抗体阳性(OR:2.3,P=0.014)显著增加血液系统复发的 odds;初始严重指标未增加复发 odds。
关键数值与推荐
- 严重血液系统指标定义:血红蛋白<8 g/dl的自身免疫性溶血性贫血、血小板计数<30 000/µL、中性粒细胞计数<500/µL。
临床怎么用
- 原文结论未给出具体推荐;作者认为预防复发对改善结局重要,对常规免疫抑制剂难治的血液系统指标患儿及抗心磷脂抗体阳性者,更严格的维持策略可能获益最大。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the severe haematological involvement in children with SLE and assess its clinical associations, treatments, outcome and damage accrual. METHODS: The medical charts of children with SLE in whom haematological involvement was observed were reviewed. Severe haematological indices were defined as autoimmune haemolytic anaemia with a haemoglobin concentration <8 g/dl, thrombocyte count <30 000/µL and neutrophil count <500/µL. RESULTS: Among the 224 patients included, 102 (45.5%) displayed severe indices, predominantly at the initial involvement, and most frequently as severe anaemia in 54 (24.1%) and severe thrombocytopenia in 45 (20.1%). Disease activity did not differ according to the presence of severe disease indices. In addition, the presence of severe indices at initial involvement did not affect the damage accrual. However, a higher rate of damage (51.1% vs 29.9%, P = 0.002) and steroid-induced damage (28.9% vs 8.2%, P < 0.001) was evident in patients with flares of the haematological system. Regression analysis revealed that rituximab treatment during the initial episode (OR: 4.5, P = 0.006) and the presence of anticardiolipin antibodies (OR: 2.3, P = 0.014) significantly increases the odds for haematological system flare. However, severe indices at initial involvement did not increase the odds of a haematological flare. CONCLUSION: Severe haematological indices at onset are common but not related with disease outcomes. Prevention of flares is important to improve outcomes, and a more rigorous maintenance strategy would benefit most to children who display haematological indices refractory to conventional immunosuppressants and those with anti-cardiolipin antibodies.
引用
- Kisaoglu H, Sener S, Demirbas KC, et al. Severe haematological involvement in children with systemic lupus erythematosus and clinical associations. Rheumatology (Oxford). 2025. PMID: 39093021. doi:10.1093/rheumatology/keae414
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。